-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HkNbZ1W2wMvpO84bYSOBcwMkD6KeNyDf4PmxuyfHfcFpGsXVZkTvCDnzrife9LIw hNkx+G1AbPJUYwzcztk5Wg== 0000875320-05-000015.txt : 20050217 0000875320-05-000015.hdr.sgml : 20050217 20050217113124 ACCESSION NUMBER: 0000875320-05-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050216 FILED AS OF DATE: 20050217 DATE AS OF CHANGE: 20050217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SATO VICKI L CENTRAL INDEX KEY: 0001197020 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 05623032 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-02-16 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197020 SATO VICKI L C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 President Common Stock 2005-02-16 4 M 0 7000 9.50 A 115108 D Common Stock 2005-02-16 4 S 0 7000 11.33 D 108108 D Common Stock 8084 I 401(k) Stock Option 9.50 2005-02-16 4 M 0 7000 0 D 1996-03-14 2005-12-13 Common Stock 7000 992819 D Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1. Right to buy under 1994 Stock and Option Plan, vesting quarterly over 5 years from 12/14/1995. Kenneth S. Boger, Attorney-In-Fact 2005-02-17 -----END PRIVACY-ENHANCED MESSAGE-----